QURE – uniQure N.V.
Float Short %
18.62
Margin Of Safety %
Put/Call OI Ratio
0.23
EPS Next Q Diff
0.08
EPS Last/This Y
2.21
EPS This/Next Y
0.1
Price
16.48
Target Price
35.17
Analyst Recom
1.14
Performance Q
3.1
Relative Volume
0.6
Beta
0.09
Ticker: QURE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | QURE | 16.19 | 0.24 | 0.79 | 69371 |
| 2025-08-18 | QURE | 15.68 | 0.19 | 0.49 | 49762 |
| 2025-08-19 | QURE | 15.34 | 0.20 | 0.06 | 49952 |
| 2025-08-20 | QURE | 15.49 | 0.20 | 0.22 | 49972 |
| 2025-08-21 | QURE | 15.47 | 0.20 | 0.31 | 51527 |
| 2025-08-22 | QURE | 15.68 | 0.20 | 2.95 | 53039 |
| 2025-08-25 | QURE | 15.56 | 0.19 | 1.18 | 53344 |
| 2025-08-26 | QURE | 15.82 | 0.21 | 0.79 | 54455 |
| 2025-08-27 | QURE | 15.78 | 0.23 | 1.60 | 56664 |
| 2025-08-28 | QURE | 16.26 | 0.24 | 1.45 | 59239 |
| 2025-08-29 | QURE | 16.34 | 0.25 | 0.16 | 59960 |
| 2025-09-02 | QURE | 17 | 0.25 | 0.05 | 59951 |
| 2025-09-03 | QURE | 17.37 | 0.22 | 0.53 | 68517 |
| 2025-09-04 | QURE | 17.73 | 0.24 | 0.11 | 68926 |
| 2025-09-05 | QURE | 18.03 | 0.24 | 0.02 | 69467 |
| 2025-09-08 | QURE | 17.44 | 0.23 | 0.58 | 71604 |
| 2025-09-09 | QURE | 17.49 | 0.24 | 0.36 | 72406 |
| 2025-09-10 | QURE | 17.48 | 0.24 | 0.18 | 72712 |
| 2025-09-11 | QURE | 16.94 | 0.22 | 1.76 | 77003 |
| 2025-09-12 | QURE | 16.48 | 0.23 | 0.43 | 77766 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | QURE | 16.19 | 8.8 | 8.1 | -2.69 |
| 2025-08-18 | QURE | 15.67 | 7.1 | 19.0 | -2.76 |
| 2025-08-19 | QURE | 15.33 | 7.1 | 17.0 | -2.76 |
| 2025-08-20 | QURE | 15.49 | 7.1 | 11.0 | -2.76 |
| 2025-08-21 | QURE | 15.56 | 7.1 | 12.1 | -2.76 |
| 2025-08-22 | QURE | 15.69 | 7.1 | 11.2 | -2.76 |
| 2025-08-25 | QURE | 15.56 | 7.1 | 14.7 | -2.76 |
| 2025-08-26 | QURE | 15.79 | 7.1 | 10.0 | -2.76 |
| 2025-08-27 | QURE | 15.75 | 7.1 | 13.5 | -2.76 |
| 2025-08-28 | QURE | 16.26 | 7.1 | 6.9 | -2.76 |
| 2025-08-29 | QURE | 16.34 | 7.1 | 12.1 | -2.76 |
| 2025-09-02 | QURE | 17.01 | 7.1 | 5.4 | -2.72 |
| 2025-09-03 | QURE | 17.39 | 7.1 | -7.0 | -2.72 |
| 2025-09-04 | QURE | 17.71 | 7.1 | -6.3 | -2.72 |
| 2025-09-05 | QURE | 17.95 | 7.4 | -4.8 | -2.71 |
| 2025-09-08 | QURE | 17.43 | 7.4 | 3.5 | -2.71 |
| 2025-09-09 | QURE | 17.48 | 7.4 | -3.0 | -2.71 |
| 2025-09-10 | QURE | 17.49 | 7.4 | -2.0 | -2.71 |
| 2025-09-11 | QURE | 16.94 | 7.4 | 3.8 | -2.71 |
| 2025-09-12 | QURE | 16.48 | 7.4 | 3.0 | -2.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | QURE | -2.29 | 26.93 | 18.89 |
| 2025-08-18 | QURE | -2.29 | 40.34 | 19.32 |
| 2025-08-19 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-20 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-21 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-22 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-25 | QURE | -1.89 | 11.15 | 19.32 |
| 2025-08-26 | QURE | -1.89 | 11.15 | 19.32 |
| 2025-08-27 | QURE | -1.89 | 11.15 | 19.99 |
| 2025-08-28 | QURE | -1.10 | 11.15 | 19.99 |
| 2025-08-29 | QURE | -1.10 | 11.15 | 19.99 |
| 2025-09-02 | QURE | -1.10 | 10.80 | 19.99 |
| 2025-09-03 | QURE | -1.10 | 10.80 | 19.99 |
| 2025-09-04 | QURE | -1.10 | 10.80 | 19.99 |
| 2025-09-05 | QURE | -1.10 | 10.80 | 19.99 |
| 2025-09-08 | QURE | -0.35 | 10.76 | 19.99 |
| 2025-09-09 | QURE | -0.35 | 10.76 | 19.99 |
| 2025-09-10 | QURE | -0.35 | 10.76 | 19.99 |
| 2025-09-11 | QURE | -0.35 | 10.76 | 18.62 |
| 2025-09-12 | QURE | -0.35 | 10.76 | 18.62 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.69
Avg. EPS Est. Current Quarter
-0.77
Avg. EPS Est. Next Quarter
-0.61
Insider Transactions
-0.35
Institutional Transactions
10.76
Beta
0.09
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
16
Fair Value
Quality Score
23
Growth Score
35
Sentiment Score
75
Actual DrawDown %
68.4
Max Drawdown 5-Year %
-92.5
Target Price
35.17
P/E
Forward P/E
PEG
P/S
63.07
P/B
P/Free Cash Flow
EPS
-3.92
Average EPS Est. Cur. Y
-2.71
EPS Next Y. (Est.)
-2.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1387.98
Relative Volume
0.6
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
3
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 209
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading